Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jul;8(3):411–426. doi: 10.1128/cmr.8.3.411

Bacterial pyrogenic exotoxins as superantigens.

M Kotb 1
PMCID: PMC174633  PMID: 7553574

Abstract

The recent discovery of the mode of interaction between a group of microbial proteins known as superantigens and the immune system has opened a wide area of investigation into the possible role of these molecules in human diseases. Superantigens produced by certain viruses and bacteria, including Mycoplasma species, are either secreted or membrane-bound proteins. A unique feature of these proteins is that they can interact simultaneously with distinct receptors on different types of cells, resulting in enhanced cell-cell interaction and triggering a series of biochemical reactions that can lead to excessive cell proliferation and the release of inflammatory cytokines. However, although superantigens share many features, they can have very different biological effects that are potentiated by host genetic and environmental factors. This review focuses on a group of secreted pyrogenic toxins that belong to the superantigen family and highlights some of their structural-functional features and their roles in diseases such as toxic shock and autoimmunity. Deciphering the biological activities of the various superantigens and understanding their role in the pathogenesis of microbial infections and their sequelae will enable us to devise means by which we can intervene with their activity and/or manipulate them to our advantage.

Full Text

The Full Text of this article is available as a PDF (424.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe J., Forrester J., Nakahara T., Lafferty J. A., Kotzin B. L., Leung D. Y. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol. 1991 Jun 1;146(11):3747–3750. [PubMed] [Google Scholar]
  2. Abe J., Takeda T., Watanabe Y., Nakao H., Kobayashi N., Leung D. Y., Kohsaka T. Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol. 1993 Oct 15;151(8):4183–4188. [PubMed] [Google Scholar]
  3. Acha-Orbea H. Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis. 1993 Mar;52 (Suppl 1):S6–16. doi: 10.1136/ard.52.suppl_1.s6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Acha-Orbea H. Roles of superantigens in microbial infections? Res Immunol. 1993 Mar-Apr;144(3):198–222. doi: 10.1016/0923-2494(93)80118-i. [DOI] [PubMed] [Google Scholar]
  5. Acharya K. R., Passalacqua E. F., Jones E. Y., Harlos K., Stuart D. I., Brehm R. D., Tranter H. S. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature. 1994 Jan 6;367(6458):94–97. doi: 10.1038/367094a0. [DOI] [PubMed] [Google Scholar]
  6. Akatsuka H., Imanishi K., Inada K., Yamashita H., Yoshida M., Uchiyama T. Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin Exp Immunol. 1994 Jun;96(3):422–426. doi: 10.1111/j.1365-2249.1994.tb06045.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Alber G., Hammer D. K., Fleischer B. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J Immunol. 1990 Jun 15;144(12):4501–4506. [PubMed] [Google Scholar]
  8. Andersson J., Nagy S., Björk L., Abrams J., Holm S., Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev. 1992 Jun;127:69–96. doi: 10.1111/j.1600-065x.1992.tb01409.x. [DOI] [PubMed] [Google Scholar]
  9. Baccala R., Kono D. H., Walker S., Balderas R. S., Theofilopoulos A. N. Genomically imposed and somatically modified human thymocyte V beta gene repertoires. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2908–2912. doi: 10.1073/pnas.88.7.2908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bartter T., Dascal A., Carroll K., Curley F. J. 'Toxic strep syndrome'. A manifestation of group A streptococcal infection. Arch Intern Med. 1988 Jun;148(6):1421–1424. doi: 10.1001/archinte.148.6.1421. [DOI] [PubMed] [Google Scholar]
  11. Beharka A. A., Armstrong J. W., Iandolo J. J., Chapes S. K. Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins. Infect Immun. 1994 Sep;62(9):3907–3915. doi: 10.1128/iai.62.9.3907-3915.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bellio M., Lone Y. C., de la Calle-Martin O., Malissen B., Abastado J. P., Kourilsky P. The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex. J Exp Med. 1994 Apr 1;179(4):1087–1097. doi: 10.1084/jem.179.4.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Benacerraf B. Antigen processing and presentation. The biologic role of MHC molecules in determinant selection. J Immunol. 1988 Oct 1;141(7 Suppl):S17–S20. [PubMed] [Google Scholar]
  14. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  15. Beutler B., Cerami A. The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655. doi: 10.1146/annurev.iy.07.040189.003205. [DOI] [PubMed] [Google Scholar]
  16. Beutner U., Rudy C., Huber B. T. Molecular characterization of Mls-1. Int Rev Immunol. 1992;8(4):279–288. doi: 10.3109/08830189209053513. [DOI] [PubMed] [Google Scholar]
  17. Bisno A. L. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991 Sep 12;325(11):783–793. doi: 10.1056/NEJM199109123251106. [DOI] [PubMed] [Google Scholar]
  18. Blackwell C. C., Saadi A. T., Raza M. W., Weir D. M., Busuttil A. The potential role of bacterial toxins in sudden infant death syndrome (SIDS). Int J Legal Med. 1993;105(6):333–338. doi: 10.1007/BF01222118. [DOI] [PubMed] [Google Scholar]
  19. Blasczyk R., Westhoff U., Grosse-Wilde H. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet. 1993 Mar 27;341(8848):789–790. doi: 10.1016/0140-6736(93)90563-v. [DOI] [PubMed] [Google Scholar]
  20. Blomster-Hautamaa D. A., Novick R. P., Schlievert P. M. Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments. J Immunol. 1986 Dec 1;137(11):3572–3576. [PubMed] [Google Scholar]
  21. Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
  22. Bohach G. A., Handley J. P., Schlievert P. M. Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1. Infect Immun. 1989 Jan;57(1):23–28. doi: 10.1128/iai.57.1.23-28.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Boitel B., Ermonval M., Panina-Bordignon P., Mariuzza R. A., Lanzavecchia A., Acuto O. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J Exp Med. 1992 Mar 1;175(3):765–777. doi: 10.1084/jem.175.3.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Bowness P., Moss P. A., Tranter H., Bell J. I., McMichael A. J. Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22. J Exp Med. 1992 Sep 1;176(3):893–896. doi: 10.1084/jem.176.3.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Braunstein N. S., Weber D. A., Wang X. C., Long E. O., Karp D. Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. J Exp Med. 1992 May 1;175(5):1301–1305. doi: 10.1084/jem.175.5.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Brocke S., Gaur A., Piercy C., Gautam A., Gijbels K., Fathman C. G., Steinman L. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature. 1993 Oct 14;365(6447):642–644. doi: 10.1038/365642a0. [DOI] [PubMed] [Google Scholar]
  27. Brostoff S. W., Howell M. D. T cell receptors, immunoregulation, and autoimmunity. Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 1):1–7. doi: 10.1016/0090-1229(92)90016-h. [DOI] [PubMed] [Google Scholar]
  28. Buelow R., O'Hehir R. E., Schreifels R., Kummerehl T. J., Riley G., Lamb J. R. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. J Immunol. 1992 Jan 1;148(1):1–6. [PubMed] [Google Scholar]
  29. Camussi G., Albano E., Tetta C., Bussolino F. The molecular action of tumor necrosis factor-alpha. Eur J Biochem. 1991 Nov 15;202(1):3–14. doi: 10.1111/j.1432-1033.1991.tb16337.x. [DOI] [PubMed] [Google Scholar]
  30. Cantor H., Crump A. L., Raman V. K., Liu H., Markowitz J. S., Grusby M. J., Glimcher L. H. Immunoregulatory effects of superantigens: interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunol Rev. 1993 Feb;131:27–42. doi: 10.1111/j.1600-065x.1993.tb01528.x. [DOI] [PubMed] [Google Scholar]
  31. Carlsson R., Fischer H., Sjögren H. O. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol. 1988 Apr 15;140(8):2484–2488. [PubMed] [Google Scholar]
  32. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S3–10. doi: 10.1016/0090-1229(92)90035-m. [DOI] [PubMed] [Google Scholar]
  33. Chatila T., Geha R. S. Signal transduction by microbial superantigens via MHC class II molecules. Immunol Rev. 1993 Feb;131:43–59. doi: 10.1111/j.1600-065x.1993.tb01529.x. [DOI] [PubMed] [Google Scholar]
  34. Chatila T., Geha R. S. Superantigens. Curr Opin Immunol. 1992 Feb;4(1):74–78. doi: 10.1016/0952-7915(92)90129-3. [DOI] [PubMed] [Google Scholar]
  35. Chesney P. J. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S1–S7. [PubMed] [Google Scholar]
  36. Chintagumpala M. M., Mollick J. A., Rich R. R. Staphylococcal toxins bind to different sites on HLA-DR. J Immunol. 1991 Dec 1;147(11):3876–3881. [PubMed] [Google Scholar]
  37. Choi Y. W., Herman A., DiGiusto D., Wade T., Marrack P., Kappler J. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature. 1990 Aug 2;346(6283):471–473. doi: 10.1038/346471a0. [DOI] [PubMed] [Google Scholar]
  38. Choi Y. W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941–8945. doi: 10.1073/pnas.86.22.8941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Choi Y., Lafferty J. A., Clements J. R., Todd J. K., Gelfand E. W., Kappler J., Marrack P., Kotzin B. L. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med. 1990 Sep 1;172(3):981–984. doi: 10.1084/jem.172.3.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Choi Y., Marrack P., Kappler J. W. Structural analysis of a mouse mammary tumor virus superantigen. J Exp Med. 1992 Mar 1;175(3):847–852. doi: 10.1084/jem.175.3.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Cleary P. P., Kaplan E. L., Handley J. P., Wlazlo A., Kim M. H., Hauser A. R., Schlievert P. M. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet. 1992 Feb 29;339(8792):518–521. doi: 10.1016/0140-6736(92)90339-5. [DOI] [PubMed] [Google Scholar]
  42. Cohen I. R. The cognitive paradigm and the immunological homunculus. Immunol Today. 1992 Dec;13(12):490–494. doi: 10.1016/0167-5699(92)90024-2. [DOI] [PubMed] [Google Scholar]
  43. Cohen I. R. The cognitive principle challenges clonal selection. Immunol Today. 1992 Nov;13(11):441–444. doi: 10.1016/0167-5699(92)90071-E. [DOI] [PubMed] [Google Scholar]
  44. Cole B. C., Atkin C. L. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today. 1991 Aug;12(8):271–276. doi: 10.1016/0167-5699(91)90125-D. [DOI] [PubMed] [Google Scholar]
  45. Cole B. C., Griffiths M. M. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum. 1993 Jul;36(7):994–1002. doi: 10.1002/art.1780360717. [DOI] [PubMed] [Google Scholar]
  46. Cole B. C. The immunobiology of Mycoplasma arthritidis and its superantigen MAM. Curr Top Microbiol Immunol. 1991;174:107–119. doi: 10.1007/978-3-642-50998-8_8. [DOI] [PubMed] [Google Scholar]
  47. Cone L. A., Woodard D. R., Schlievert P. M., Tomory G. S. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987 Jul 16;317(3):146–149. doi: 10.1056/NEJM198707163170305. [DOI] [PubMed] [Google Scholar]
  48. Cowan M. R., Primm P. A., Scott S. M., Abramo T. J., Wiebe R. A. Serious group A beta-hemolytic streptococcal infections complicating varicella. Ann Emerg Med. 1994 Apr;23(4):818–822. doi: 10.1016/s0196-0644(94)70320-5. [DOI] [PubMed] [Google Scholar]
  49. Davies T. F., Martin A., Concepcion E. S., Graves P., Cohen L., Ben-Nun A. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med. 1991 Jul 25;325(4):238–244. doi: 10.1056/NEJM199107253250404. [DOI] [PubMed] [Google Scholar]
  50. Davis J. P., Chesney P. J., Wand P. J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980 Dec 18;303(25):1429–1435. doi: 10.1056/NEJM198012183032501. [DOI] [PubMed] [Google Scholar]
  51. Davis M. M., Bjorkman P. J. T-cell antigen receptor genes and T-cell recognition. Nature. 1988 Aug 4;334(6181):395–402. doi: 10.1038/334395a0. [DOI] [PubMed] [Google Scholar]
  52. Dellabona P., Peccoud J., Kappler J., Marrack P., Benoist C., Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell. 1990 Sep 21;62(6):1115–1121. doi: 10.1016/0092-8674(90)90388-u. [DOI] [PubMed] [Google Scholar]
  53. Demers B., Low D. E., Simor A. E., Vellend H., Jamieson F., Walmsley S., Green K., Krishnan C. Severe group A streptococcal disease--southern Ontario. Ontario Streptococcal Study Group. Can Dis Wkly Rep. 1991 Aug 31;17(35):192–194. [PubMed] [Google Scholar]
  54. Dinarello C. A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis. 1991 Jun;163(6):1177–1184. doi: 10.1093/infdis/163.6.1177. [DOI] [PubMed] [Google Scholar]
  55. Dinarello C. A., Wolff S. M. The role of interleukin-1 in disease. N Engl J Med. 1993 Jan 14;328(2):106–113. doi: 10.1056/NEJM199301143280207. [DOI] [PubMed] [Google Scholar]
  56. Dohlsten M., Hedlund G., Akerblom E., Lando P. A., Kalland T. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9287–9291. doi: 10.1073/pnas.88.20.9287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Dohlsten M., Hedlund G., Kalland T. Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity. Immunol Today. 1991 May;12(5):147–150. doi: 10.1016/S0167-5699(05)80043-X. [DOI] [PubMed] [Google Scholar]
  58. Dohlsten M., Hedlund G., Lando P. A., Trowsdale J., Altmann D., Patarroyo M., Fischer H., Kalland T. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity. Eur J Immunol. 1991 Jan;21(1):131–135. doi: 10.1002/eji.1830210120. [DOI] [PubMed] [Google Scholar]
  59. Dohlsten M., Hedlund G., Segren S., Lando P. A., Herrmann T., Kelly A. P., Kalland T. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur J Immunol. 1991 May;21(5):1229–1233. doi: 10.1002/eji.1830210520. [DOI] [PubMed] [Google Scholar]
  60. Dohlsten M., Lando P. A., Hedlund G., Trowsdale J., Kalland T. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins. Immunology. 1990 Sep;71(1):96–100. [PMC free article] [PubMed] [Google Scholar]
  61. Dohlsten M., Sundstedt A., Björklund M., Hedlund G., Kalland T. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer. 1993 May 28;54(3):482–488. doi: 10.1002/ijc.2910540321. [DOI] [PubMed] [Google Scholar]
  62. Drake C. G., Kotzin B. L. Superantigens: biology, immunology, and potential role in disease. J Clin Immunol. 1992 May;12(3):149–162. doi: 10.1007/BF00918083. [DOI] [PubMed] [Google Scholar]
  63. Edwin C., Kass E. H. Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments. Infect Immun. 1989 Jul;57(7):2230–2236. doi: 10.1128/iai.57.7.2230-2236.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Ericsson P. O., Hansson J., Widegren B., Dohlsten M., Sjögren H. O., Hedlund G. In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity. Eur J Immunol. 1991 Nov;21(11):2797–2802. doi: 10.1002/eji.1830211122. [DOI] [PubMed] [Google Scholar]
  65. Estrada C., Gómez C., Martín C., Moncada S., González C. Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. Biochem Biophys Res Commun. 1992 Jul 15;186(1):475–482. doi: 10.1016/s0006-291x(05)80832-0. [DOI] [PubMed] [Google Scholar]
  66. Fast D. J., Schlievert P. M., Nelson R. D. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun. 1989 Jan;57(1):291–294. doi: 10.1128/iai.57.1.291-294.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Ferradini L., Roman-Roman S., Azocar J., Michalaki H., Triebel F., Hercend T. Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamilies. Eur J Immunol. 1991 Apr;21(4):935–942. doi: 10.1002/eji.1830210412. [DOI] [PubMed] [Google Scholar]
  68. Fischer H., Dohlsten M., Lindvall M., Sjögren H. O., Carlsson R. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol. 1989 May 1;142(9):3151–3157. [PubMed] [Google Scholar]
  69. Fleischer B., Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med. 1988 May 1;167(5):1697–1707. doi: 10.1084/jem.167.5.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Fraser J. D. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature. 1989 May 18;339(6221):221–223. doi: 10.1038/339221a0. [DOI] [PubMed] [Google Scholar]
  71. Fraser J. D., Urban R. G., Strominger J. L., Robinson H. Zinc regulates the function of two superantigens. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5507–5511. doi: 10.1073/pnas.89.12.5507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Friedman S. M., Posnett D. N., Tumang J. R., Cole B. C., Crow M. K. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum. 1991 Apr;34(4):468–480. doi: 10.1002/art.1780340412. [DOI] [PubMed] [Google Scholar]
  73. Friedman S. M., Tumang J. R., Crow M. K. Microbial superantigens as etiopathogenic agents in autoimmunity. Rheum Dis Clin North Am. 1993 Feb;19(1):207–222. [PubMed] [Google Scholar]
  74. Fuleihan R., Mourad W., Geha R. S., Chatila T. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells. J Immunol. 1991 Mar 1;146(5):1661–1666. [PubMed] [Google Scholar]
  75. Gascoigne N. R., Ames K. T. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):613–616. doi: 10.1073/pnas.88.2.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Gascoigne N. R. Interaction of the T cell receptor with bacterial superantigens. Semin Immunol. 1993 Feb;5(1):13–21. doi: 10.1006/smim.1993.1003. [DOI] [PubMed] [Google Scholar]
  77. Gaworzewska E., Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect. 1988 Apr;100(2):257–269. doi: 10.1017/s095026880006739x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Gjörloff A., Fischer H., Hedlund G., Hansson J., Kenney J. S., Allison A. C., Sjögren H. O., Dohlsten M. Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells. Cell Immunol. 1991 Oct 1;137(1):61–71. doi: 10.1016/0008-8749(91)90056-h. [DOI] [PubMed] [Google Scholar]
  79. Glass K. L., Dillard T. A., Dennis G. J., Dacey M. J., Dwyer T. X. Pyogenic arthritis complicating varicella infection. South Med J. 1994 Aug;87(8):857–859. doi: 10.1097/00007611-199408000-00025. [DOI] [PubMed] [Google Scholar]
  80. Glimcher L. H., Kara C. J. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol. 1992;10:13–49. doi: 10.1146/annurev.iy.10.040192.000305. [DOI] [PubMed] [Google Scholar]
  81. Grossman D., Lamphear J. G., Mollick J. A., Betley M. J., Rich R. R. Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun. 1992 Dec;60(12):5190–5196. doi: 10.1128/iai.60.12.5190-5196.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Grossman D., Van M., Mollick J. A., Highlander S. K., Rich R. R. Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol. 1991 Nov 15;147(10):3274–3281. [PubMed] [Google Scholar]
  83. Hackett S. P., Stevens D. L. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis. 1992 May;165(5):879–885. doi: 10.1093/infdis/165.5.879. [DOI] [PubMed] [Google Scholar]
  84. Hall B. L., Finn O. J. PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity. Biotechniques. 1992 Aug;13(2):248–257. [PubMed] [Google Scholar]
  85. Hamilos D. L. Antigen presenting cells. Immunol Res. 1989;8(2):98–117. doi: 10.1007/BF02919073. [DOI] [PubMed] [Google Scholar]
  86. Hansson J., Ericsson P. O., Dohlsten M., Sjögren H. O., Kalland T., Hedlund G. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells. Immunol Lett. 1992 Dec;34(3):229–236. doi: 10.1016/0165-2478(92)90218-d. [DOI] [PubMed] [Google Scholar]
  87. Hauser A. R., Stevens D. L., Kaplan E. L., Schlievert P. M. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol. 1991 Aug;29(8):1562–1567. doi: 10.1128/jcm.29.8.1562-1567.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Hedlund G., Dohlsten M., Herrmann T., Buell G., Lando P. A., Segrén S., Schrimsher J., MacDonald H. R., Sjögren H. O., Kalland T. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol. 1991 Dec 15;147(12):4082–4085. [PubMed] [Google Scholar]
  89. Hedlund G., Dohlsten M., Lando P. A., Kalland T. Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells. Cell Immunol. 1990 Sep;129(2):426–434. doi: 10.1016/0008-8749(90)90218-g. [DOI] [PubMed] [Google Scholar]
  90. Hedlund G., Dohlsten M., Petersson C., Kalland T. Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells. Cancer Immunol Immunother. 1993;36(2):89–93. doi: 10.1007/BF01754407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Henne E., Campbell W. H., Carlson E. Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice. Infect Immun. 1991 Sep;59(9):2929–2933. doi: 10.1128/iai.59.9.2929-2933.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Hensler T., Köller M., Geoffroy C., Alouf J. E., König W. Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils. Infect Immun. 1993 Mar;61(3):1055–1061. doi: 10.1128/iai.61.3.1055-1061.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Herman A., Croteau G., Sekaly R. P., Kappler J., Marrack P. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med. 1990 Sep 1;172(3):709–717. doi: 10.1084/jem.172.3.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Herman A., Kappler J. W., Marrack P., Pullen A. M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol. 1991;9:745–772. doi: 10.1146/annurev.iy.09.040191.003525. [DOI] [PubMed] [Google Scholar]
  95. Herman A., Labrecque N., Thibodeau J., Marrack P., Kappler J. W., Sekaly R. P. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9954–9958. doi: 10.1073/pnas.88.22.9954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Hewitt C. R., Lamb J. R., Hayball J., Hill M., Owen M. J., O'Hehir R. E. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med. 1992 Jun 1;175(6):1493–1499. doi: 10.1084/jem.175.6.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Higgins P. M. Splenomegaly in acute infections due to group A streptococci and viruses. Epidemiol Infect. 1992 Oct;109(2):199–209. doi: 10.1017/s0950268800050160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Hodes R. J., Abe R. T cell recognition of Mls-like superantigens: analysis of TCR requirements, superantigenic ligands, and signal transduction. Semin Immunol. 1992 Oct;4(5):319–327. [PubMed] [Google Scholar]
  99. Hoffmann M. L., Jablonski L. M., Crum K. K., Hackett S. P., Chi Y. I., Stauffacher C. V., Stevens D. L., Bohach G. A. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun. 1994 Aug;62(8):3396–3407. doi: 10.1128/iai.62.8.3396-3407.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Hoge C. W., Schwartz B., Talkington D. F., Breiman R. F., MacNeill E. M., Englender S. J. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993 Jan 20;269(3):384–389. [PubMed] [Google Scholar]
  101. Holm S. E., Norrby A., Bergholm A. M., Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis. 1992 Jul;166(1):31–37. doi: 10.1093/infdis/166.1.31. [DOI] [PubMed] [Google Scholar]
  102. Howell M. D., Diveley J. P., Lundeen K. A., Esty A., Winters S. T., Carlo D. J., Brostoff S. W. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10921–10925. doi: 10.1073/pnas.88.23.10921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Huang L., Crispe I. N. Superantigen-driven peripheral deletion of T cells. Apoptosis occurs in cells that have lost the alpha/beta T cell receptor. J Immunol. 1993 Aug 15;151(4):1844–1851. [PubMed] [Google Scholar]
  104. Huber B. T. Mls superantigens: how retroviruses influence the expressed T cell receptor repertoire. Semin Immunol. 1992 Oct;4(5):313–318. [PubMed] [Google Scholar]
  105. Hudson K. R., Robinson H., Fraser J. D. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity. J Exp Med. 1993 Jan 1;177(1):175–184. doi: 10.1084/jem.177.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Ikejima T., Dinarello C. A., Gill D. M., Wolff S. M. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest. 1984 May;73(5):1312–1320. doi: 10.1172/JCI111334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Imanishi K., Igarashi H., Uchiyama T. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B. Infect Immun. 1992 Dec;60(12):5025–5029. doi: 10.1128/iai.60.12.5025-5029.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Imberti L., Sottini A., Bettinardi A., Puoti M., Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science. 1991 Nov 8;254(5033):860–862. doi: 10.1126/science.1948066. [DOI] [PubMed] [Google Scholar]
  109. Imberti L., Sottini A., Primi D. T cell repertoire and autoimmune diseases. Immunol Res. 1993;12(2):149–167. doi: 10.1007/BF02918301. [DOI] [PubMed] [Google Scholar]
  110. Irwin M. J., Hudson K. R., Ames K. T., Fraser J. D., Gascoigne N. R. T-cell receptor beta-chain binding to enterotoxin superantigens. Immunol Rev. 1993 Feb;131:61–78. doi: 10.1111/j.1600-065x.1993.tb01530.x. [DOI] [PubMed] [Google Scholar]
  111. Irwin M. J., Hudson K. R., Fraser J. D., Gascoigne N. R. Enterotoxin residues determining T-cell receptor V beta binding specificity. Nature. 1992 Oct 29;359(6398):841–843. doi: 10.1038/359841a0. [DOI] [PubMed] [Google Scholar]
  112. Ispahani P., Donald F. E., Aveline A. J. Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated. J Infect. 1988 Jan;16(1):37–46. doi: 10.1016/s0163-4453(88)96073-2. [DOI] [PubMed] [Google Scholar]
  113. Janeway C. A., Jr, Rath S., Yagi J. V beta selective elements: self and non-self. Behring Inst Mitt. 1991 Feb;(88):177–182. [PubMed] [Google Scholar]
  114. Janeway C. A., Jr, Yagi J., Conrad P. J., Katz M. E., Jones B., Vroegop S., Buxser S. T-cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol Rev. 1989 Feb;107:61–88. doi: 10.1111/j.1600-065x.1989.tb00003.x. [DOI] [PubMed] [Google Scholar]
  115. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
  116. Jenkins M. K., Taylor P. S., Norton S. D., Urdahl K. B. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol. 1991 Oct 15;147(8):2461–2466. [PubMed] [Google Scholar]
  117. Johnson H. M., Russell J. K., Pontzer C. H. Staphylococcal enterotoxin microbial superantigens. FASEB J. 1991 Sep;5(12):2706–2712. doi: 10.1096/fasebj.5.12.1916093. [DOI] [PubMed] [Google Scholar]
  118. Johnson H. M., Russell J. K., Pontzer C. H. Staphylococcal enterotoxin superantigens. Proc Soc Exp Biol Med. 1991 Dec;198(3):765–771. doi: 10.3181/00379727-198-43321a. [DOI] [PubMed] [Google Scholar]
  119. Johnson H. M., Russell J. K., Pontzer C. H. Superantigens in human disease. Sci Am. 1992 Apr;266(4):92-5, 98-101. doi: 10.1038/scientificamerican0492-92. [DOI] [PubMed] [Google Scholar]
  120. Jupin C., Anderson S., Damais C., Alouf J. E., Parant M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med. 1988 Mar 1;167(3):752–761. doi: 10.1084/jem.167.3.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Kalland T., Dohlsten M., Lind P., Sundstedt A., Abrahmsén L., Hedlund G., Björk P., Lando P. A., Björklund M. Monoclonal antibodies and superantigens: a novel therapeutic approach. Med Oncol Tumor Pharmacother. 1993;10(1-2):37–47. doi: 10.1007/BF02987767. [DOI] [PubMed] [Google Scholar]
  122. Kalland T., Hedlund G., Dohlsten M., Lando P. A. Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity. Curr Top Microbiol Immunol. 1991;174:81–92. doi: 10.1007/978-3-642-50998-8_6. [DOI] [PubMed] [Google Scholar]
  123. Kappler J. W., Herman A., Clements J., Marrack P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med. 1992 Feb 1;175(2):387–396. doi: 10.1084/jem.175.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Kappler J., Kotzin B., Herron L., Gelfand E. W., Bigler R. D., Boylston A., Carrel S., Posnett D. N., Choi Y., Marrack P. V beta-specific stimulation of human T cells by staphylococcal toxins. Science. 1989 May 19;244(4906):811–813. doi: 10.1126/science.2524876. [DOI] [PubMed] [Google Scholar]
  125. Karp D. R. Analyses of the staphylococcal toxin binding sites on MHC class II molecules. Res Immunol. 1993 Mar-Apr;144(3):181–222. doi: 10.1016/0923-2494(93)80114-e. [DOI] [PubMed] [Google Scholar]
  126. Karp D. R., Long E. O. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. J Exp Med. 1992 Feb 1;175(2):415–424. doi: 10.1084/jem.175.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Karp D. R., Teletski C. L., Scholl P., Geha R., Long E. O. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature. 1990 Aug 2;346(6283):474–476. doi: 10.1038/346474a0. [DOI] [PubMed] [Google Scholar]
  128. Kawabe Y., Ochi A. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature. 1991 Jan 17;349(6306):245–248. doi: 10.1038/349245a0. [DOI] [PubMed] [Google Scholar]
  129. Kawabe Y., Ochi A. Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med. 1990 Oct 1;172(4):1065–1070. doi: 10.1084/jem.172.4.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Kawamura T., Nagata M., Utsugi T., Yoon J. W. Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice. J Immunol. 1993 Oct 15;151(8):4362–4370. [PubMed] [Google Scholar]
  131. Kilbourn R. G., Jubran A., Gross S. S., Griffith O. W., Levi R., Adams J., Lodato R. F. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun. 1990 Nov 15;172(3):1132–1138. doi: 10.1016/0006-291x(90)91565-a. [DOI] [PubMed] [Google Scholar]
  132. Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol. 1995 Jan;74(1):10–22. doi: 10.1006/clin.1995.1003. [DOI] [PubMed] [Google Scholar]
  133. Kotb M., Majumdar G., Tomai M., Beachey E. H. Accessory cell-independent stimulation of human T cells by streptococcal M protein superantigen. J Immunol. 1990 Sep 1;145(5):1332–1336. [PubMed] [Google Scholar]
  134. Kotb M., Ohnishi H., Majumdar G., Hackett S., Bryant A., Higgins G., Stevens D. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5. Infect Immun. 1993 Apr;61(4):1194–1201. doi: 10.1128/iai.61.4.1194-1201.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Kotb M., Watanabe-Ohnishi R., Aelion J., Tanaka T., Geller A. M., Ohnishi H. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules. Cell Immunol. 1993 Dec;152(2):348–357. doi: 10.1006/cimm.1993.1296. [DOI] [PubMed] [Google Scholar]
  136. Kotzin B. L., Karuturi S., Chou Y. K., Lafferty J., Forrester J. M., Better M., Nedwin G. E., Offner H., Vandenbark A. A. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9161–9165. doi: 10.1073/pnas.88.20.9161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Kotzin B. L., Leung D. Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99–166. doi: 10.1016/s0065-2776(08)60534-9. [DOI] [PubMed] [Google Scholar]
  138. Kronenberg M., Siu G., Hood L. E., Shastri N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu Rev Immunol. 1986;4:529–591. doi: 10.1146/annurev.iy.04.040186.002525. [DOI] [PubMed] [Google Scholar]
  139. Köhler W. Epidemiologie und Pathogenese von Streptokokkeninfektionen. Immun Infekt. 1992 Jul;20(3):92–98. [PubMed] [Google Scholar]
  140. Lando P. A., Dohlsten M., Hedlund G., Akerblom E., Kalland T. T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens. Cancer Immunol Immunother. 1993;36(4):223–228. doi: 10.1007/BF01740903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Lando P. A., Hedlund G., Dohlsten M., Kalland T. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. Cancer Immunol Immunother. 1991;33(4):231–237. doi: 10.1007/BF01744942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Lappe M. A. Silicone-reactive disorder: a new autoimmune disease caused by immunostimulation and superantigens. Med Hypotheses. 1993 Oct;41(4):348–352. doi: 10.1016/0306-9877(93)90081-z. [DOI] [PubMed] [Google Scholar]
  143. Laster S. M., Wood J. G., Gooding L. R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol. 1988 Oct 15;141(8):2629–2634. [PubMed] [Google Scholar]
  144. Laurence J., Hodtsev A. S., Posnett D. N. Superantigens in infectious diseases, including AIDS. Ann N Y Acad Sci. 1993 Jun 23;685:746–755. doi: 10.1111/j.1749-6632.1993.tb35936.x. [DOI] [PubMed] [Google Scholar]
  145. Ledbetter J. A., Imboden J. B., Schieven G. L., Grosmaire L. S., Rabinovitch P. S., Lindsten T., Thompson C. B., June C. H. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood. 1990 Apr 1;75(7):1531–1539. [PubMed] [Google Scholar]
  146. Lee P. K., Schlievert P. M. Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus. Curr Top Microbiol Immunol. 1991;174:1–19. doi: 10.1007/978-3-642-50998-8_1. [DOI] [PubMed] [Google Scholar]
  147. Lee P. K., Vercellotti G. M., Deringer J. R., Schlievert P. M. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J Infect Dis. 1991 Oct;164(4):711–719. doi: 10.1093/infdis/164.4.711. [DOI] [PubMed] [Google Scholar]
  148. Legaard P. K., LeGrand R. D., Misfeldt M. L. The superantigen Pseudomonas exotoxin A requires additional functions from accessory cells for T lymphocyte proliferation. Cell Immunol. 1991 Jul;135(2):372–382. doi: 10.1016/0008-8749(91)90282-g. [DOI] [PubMed] [Google Scholar]
  149. Lentz S. R., Tsiang M., Sadler J. E. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood. 1991 Feb 1;77(3):542–550. [PubMed] [Google Scholar]
  150. Leonard B. A., Schlievert P. M. Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin. Infect Immun. 1992 Sep;60(9):3747–3755. doi: 10.1128/iai.60.9.3747-3755.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Leung D. Y. Kawasaki disease. Curr Opin Rheumatol. 1993 Jan;5(1):41–50. doi: 10.1097/00002281-199305010-00007. [DOI] [PubMed] [Google Scholar]
  152. Leung D. Y., Meissner H. C., Fulton D. R., Murray D. L., Kotzin B. L., Schlievert P. M. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4;342(8884):1385–1388. doi: 10.1016/0140-6736(93)92752-f. [DOI] [PubMed] [Google Scholar]
  153. Leung D. Y., Walsh P., Giorno R., Norris D. A. A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol. 1993 Mar;100(3):225–228. doi: 10.1111/1523-1747.ep12468941. [DOI] [PubMed] [Google Scholar]
  154. Lewis H. M., Baker B. S., Bokth S., Powles A. V., Garioch J. J., Valdimarsson H., Fry L. Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol. 1993 Nov;129(5):514–520. doi: 10.1111/j.1365-2133.1993.tb00477.x. [DOI] [PubMed] [Google Scholar]
  155. Majumdar G., Beachey E. H., Tomai M., Kotb M. Differential signal requirements in T-cell activation by mitogen and superantigen. Cell Signal. 1990;2(6):521–530. doi: 10.1016/0898-6568(90)90074-k. [DOI] [PubMed] [Google Scholar]
  156. Majumdar G., Ohnishi H., Tomai M. A., Geller A. M., Wang B., Dockter M. E., Kotb M. Role of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factors. Infect Immun. 1993 Feb;61(2):785–790. doi: 10.1128/iai.61.2.785-790.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Marrack P., Kappler J. Subversion of the immune system by pathogens. Cell. 1994 Jan 28;76(2):323–332. doi: 10.1016/0092-8674(94)90339-5. [DOI] [PubMed] [Google Scholar]
  158. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  159. Martin P. R., Høiby E. A. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis. 1990;22(4):421–429. doi: 10.3109/00365549009027073. [DOI] [PubMed] [Google Scholar]
  160. Martin R., Howell M. D., Jaraquemada D., Flerlage M., Richert J., Brostoff S., Long E. O., McFarlin D. E., McFarland H. F. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med. 1991 Jan 1;173(1):19–24. doi: 10.1084/jem.173.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. McCormack J. E., Callahan J. E., Kappler J., Marrack P. C. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol. 1993 May 1;150(9):3785–3792. [PubMed] [Google Scholar]
  162. Melish M. E., Murata S., Fukunaga C., Frogner K., McKissick C. Vaginal tampon model for toxic shock syndrome. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S238–S247. doi: 10.1093/clinids/11.supplement_1.s238. [DOI] [PubMed] [Google Scholar]
  163. Micusan V. V., Desrosiers M., Gosselin J., Mercier G., Oth D., Bhatti A. R., Heremans H., Billiau A. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S305–S312. doi: 10.1093/clinids/11.supplement_1.s305. [DOI] [PubMed] [Google Scholar]
  164. Miethke T., Gaus H., Wahl C., Heeg K., Wagner H. T-cell-dependent shock induced by a bacterial superantigen. Chem Immunol. 1992;55:172–184. [PubMed] [Google Scholar]
  165. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P. H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 1992 Jan 1;175(1):91–98. doi: 10.1084/jem.175.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Mollick J. A., Chintagumpala M., Cook R. G., Rich R. R. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol. 1991 Jan 15;146(2):463–468. [PubMed] [Google Scholar]
  167. Mollick J. A., Cook R. G., Rich R. R. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science. 1989 May 19;244(4906):817–820. doi: 10.1126/science.2658055. [DOI] [PubMed] [Google Scholar]
  168. Mollick J. A., McMasters R. L., Grossman D., Rich R. R. Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med. 1993 Feb 1;177(2):283–293. doi: 10.1084/jem.177.2.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Mollick J. A., Miller G. G., Musser J. M., Cook R. G., Grossman D., Rich R. R. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest. 1993 Aug;92(2):710–719. doi: 10.1172/JCI116641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  171. Morris J. A., Haran D., Smith A. Hypothesis: common bacterial toxins are a possible cause of the sudden infant death syndrome. Med Hypotheses. 1987 Feb;22(2):211–222. doi: 10.1016/0306-9877(87)90145-9. [DOI] [PubMed] [Google Scholar]
  172. Mourad W., al-Daccak R., Chatila T., Geha R. S. Staphylococcal superantigens as inducers of signal transduction in MHC class II-positive cells. Semin Immunol. 1993 Feb;5(1):47–55. doi: 10.1006/smim.1993.1007. [DOI] [PubMed] [Google Scholar]
  173. Musser J. M., Hauser A. R., Kim M. H., Schlievert P. M., Nelson K., Selander R. K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668–2672. doi: 10.1073/pnas.88.7.2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Nadal D., Lauener R. P., Braegger C. P., Kaufhold A., Simma B., Lütticken R., Seger R. A. T cell activation and cytokine release in streptococcal toxic shock-like syndrome. J Pediatr. 1993 May;122(5 Pt 1):727–729. doi: 10.1016/s0022-3476(06)80014-4. [DOI] [PubMed] [Google Scholar]
  175. Nelson K., Schlievert P. M., Selander R. K., Musser J. M. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med. 1991 Nov 1;174(5):1271–1274. doi: 10.1084/jem.174.5.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Newell K. A., Ellenhorn J. D., Bruce D. S., Bluestone J. A. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1074–1078. doi: 10.1073/pnas.88.3.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Norgren M., Norrby A., Holm S. E. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis. 1992 Nov;166(5):1014–1020. doi: 10.1093/infdis/166.5.1014. [DOI] [PubMed] [Google Scholar]
  178. Norrby-Teglund A., Newton D., Kotb M., Holm S. E., Norgren M. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun. 1994 Dec;62(12):5227–5233. doi: 10.1128/iai.62.12.5227-5233.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Norrby-Teglund A., Norgren M., Holm S. E., Andersson U., Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun. 1994 Sep;62(9):3731–3738. doi: 10.1128/iai.62.9.3731-3738.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Norrby-Teglund A., Pauksens K., Holm S. E., Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis. 1994 Sep;170(3):585–591. doi: 10.1093/infdis/170.3.585. [DOI] [PubMed] [Google Scholar]
  181. Nygard N. R., Schwartz B. D. Infection and autoimmunity. Adv Intern Med. 1993;38:337–359. [PubMed] [Google Scholar]
  182. O'Hehir R. E., Lamb J. R. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8884–8888. doi: 10.1073/pnas.87.22.8884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Ochi A., Migita K., Xu J., Siminovitch K. In vivo tumor immunotherapy by a bacterial superantigen. J Immunol. 1993 Sep 15;151(6):3180–3186. [PubMed] [Google Scholar]
  184. Ochi A., Yuh K., Migita K. Not every superantigen induces tolerance in vivo. Semin Immunol. 1993 Feb;5(1):57–63. doi: 10.1006/smim.1993.1008. [DOI] [PubMed] [Google Scholar]
  185. Offner H., Buenafe A. C., Vainiene M., Celnik B., Weinberg A. D., Gold D. P., Hashim G., Vandenbark A. A. Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol. 1993 Jul 1;151(1):506–517. [PubMed] [Google Scholar]
  186. Offner H., Vainiene M., Gold D. P., Morrison W. J., Wang R. Y., Hashim G. A., Vandenbark A. A. Protection against experimental encephalomyelitis. Idiotypic autoregulation induced by a nonencephalitogenic T cell clone expressing a cross-reactive T cell receptor V gene. J Immunol. 1991 Jun 15;146(12):4165–4172. [PubMed] [Google Scholar]
  187. Ohnishi H., Tanaka T., Takahara J., Kotb M. CD28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting cell-depleted human T lymphocytes. J Immunol. 1993 Apr 15;150(8 Pt 1):3207–3214. [PubMed] [Google Scholar]
  188. Oksenberg J. R., Panzara M. A., Begovich A. B., Mitchell D., Erlich H. A., Murray R. S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C. C. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993 Mar 4;362(6415):68–70. doi: 10.1038/362068a0. [DOI] [PubMed] [Google Scholar]
  189. Oksenberg J. R., Stuart S., Begovich A. B., Bell R. B., Erlich H. A., Steinman L., Bernard C. C. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature. 1990 May 24;345(6273):344–346. doi: 10.1038/345344a0. [DOI] [PubMed] [Google Scholar]
  190. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988 Apr;81(4):1162–1172. doi: 10.1172/JCI113431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Paliard X., West S. G., Lafferty J. A., Clements J. R., Kappler J. W., Marrack P., Kotzin B. L. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 1991 Jul 19;253(5017):325–329. doi: 10.1126/science.1857971. [DOI] [PubMed] [Google Scholar]
  192. Panina-Bordignon P., Fu X. T., Lanzavecchia A., Karr R. W. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen. J Exp Med. 1992 Dec 1;176(6):1779–1784. doi: 10.1084/jem.176.6.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Parsonnet J., Hickman R. K., Eardley D. D., Pier G. B. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis. 1985 Mar;151(3):514–522. doi: 10.1093/infdis/151.3.514. [DOI] [PubMed] [Google Scholar]
  194. Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S263–S269. doi: 10.1093/clinids/11.supplement_1.s263. [DOI] [PubMed] [Google Scholar]
  195. Patten P. A., Rock E. P., Sonoda T., Fazekas de St Groth B., Jorgensen J. L., Davis M. M. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J Immunol. 1993 Mar 15;150(6):2281–2294. [PubMed] [Google Scholar]
  196. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991 Dec 21;338(8782-8783):1557–1558. doi: 10.1016/0140-6736(91)92376-d. [DOI] [PubMed] [Google Scholar]
  197. Pontzer C. H., Irwin M. J., Gascoigne N. R., Johnson H. M. T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7727–7731. doi: 10.1073/pnas.89.16.7727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Pontzer C. H., Russell J. K., Johnson H. M. Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. J Immunol. 1989 Jul 1;143(1):280–284. [PubMed] [Google Scholar]
  199. Pontzer C. H., Russell J. K., Johnson H. M. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):125–128. doi: 10.1073/pnas.88.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Prasad G. S., Earhart C. A., Murray D. L., Novick R. P., Schlievert P. M., Ohlendorf D. H. Structure of toxic shock syndrome toxin 1. Biochemistry. 1993 Dec 21;32(50):13761–13766. doi: 10.1021/bi00213a001. [DOI] [PubMed] [Google Scholar]
  201. Pullen A. M., Bill J., Kubo R. T., Marrack P., Kappler J. W. Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta. J Exp Med. 1991 May 1;173(5):1183–1192. doi: 10.1084/jem.173.5.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Pullen A. M., Choi Y., Kushnir E., Kappler J., Marrack P. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. J Exp Med. 1992 Jan 1;175(1):41–47. doi: 10.1084/jem.175.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Quinn R. W. Epidemiology of group A streptococcal infections--their changing frequency and severity. Yale J Biol Med. 1982 May-Aug;55(3-4):265–270. [PMC free article] [PubMed] [Google Scholar]
  204. Reck B., Scheuber P. H., Londong W., Sailer-Kramer B., Bartsch K., Hammer D. K. Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies. Proc Natl Acad Sci U S A. 1988 May;85(9):3170–3174. doi: 10.1073/pnas.85.9.3170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Reda K. B., Kapur V., Mollick J. A., Lamphear J. G., Musser J. M., Rich R. R. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun. 1994 May;62(5):1867–1874. doi: 10.1128/iai.62.5.1867-1874.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Rellahan B. L., Jones L. A., Kruisbeek A. M., Fry A. M., Matis L. A. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med. 1990 Oct 1;172(4):1091–1100. doi: 10.1084/jem.172.4.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Roman-Roman S., Ferradini L., Azocar J., Genevée C., Hercend T., Triebel F. Studies on the human T cell receptor alpha/beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segments. Eur J Immunol. 1991 Apr;21(4):927–933. doi: 10.1002/eji.1830210411. [DOI] [PubMed] [Google Scholar]
  208. Rosenwasser O. A., Fairchild S., Tomonari K. New superantigen specificity created by two amino acid replacements. Immunogenetics. 1993;38(5):367–369. doi: 10.1007/BF00210480. [DOI] [PubMed] [Google Scholar]
  209. SUGIYAMA H., MCKISSIC E. M., Jr, BERGDOLL M. S., HELLER B. ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN. J Infect Dis. 1964 Apr;114:111–118. doi: 10.1093/infdis/114.2.111. [DOI] [PubMed] [Google Scholar]
  210. Satyanarayana K., Chou Y. K., Bourdette D., Whitham R., Hashim G. A., Offner H., Vandenbark A. A. Epitope specificity and V gene expression of cerebrospinal fluid T cells specific for intact versus cryptic epitopes of myelin basic protein. J Neuroimmunol. 1993 Apr;44(1):57–67. doi: 10.1016/0165-5728(93)90268-4. [DOI] [PubMed] [Google Scholar]
  211. Scherer M. T., Ignatowicz L., Winslow G. M., Kappler J. W., Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol. 1993;9:101–128. doi: 10.1146/annurev.cb.09.110193.000533. [DOI] [PubMed] [Google Scholar]
  212. Scheuber P. H., Golecki J. R., Kickhöfen B., Scheel D., Beck G., Hammer D. K. Skin reactivity of unsensitized monkeys upon challenge with staphylococcal enterotoxin B: a new approach for investigating the site of toxin action. Infect Immun. 1985 Dec;50(3):869–876. doi: 10.1128/iai.50.3.869-876.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Schiffenbauer J., Johnson H. M., Butfiloski E. J., Wegrzyn L., Soos J. M. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8543–8546. doi: 10.1073/pnas.90.18.8543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Schlievert P. M. Role of superantigens in human disease. J Infect Dis. 1993 May;167(5):997–1002. doi: 10.1093/infdis/167.5.997. [DOI] [PubMed] [Google Scholar]
  215. Schlievert P. M. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet. 1986 May 17;1(8490):1149–1150. doi: 10.1016/s0140-6736(86)91859-3. [DOI] [PubMed] [Google Scholar]
  216. Scholl P. R., Diez A., Geha R. S. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J Immunol. 1989 Oct 15;143(8):2583–2588. [PubMed] [Google Scholar]
  217. Scholl P. R., Diez A., Karr R., Sekaly R. P., Trowsdale J., Geha R. S. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J Immunol. 1990 Jan 1;144(1):226–230. [PubMed] [Google Scholar]
  218. Scholl P., Diez A., Mourad W., Parsonnet J., Geha R. S., Chatila T. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4210–4214. doi: 10.1073/pnas.86.11.4210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Schwab J. H., Brown R. R., Anderle S. K., Schlievert P. M. Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol. 1993 May 1;150(9):4151–4159. [PubMed] [Google Scholar]
  220. Schwartz B. D. Infectious agents, immunity, and rheumatic diseases. Arthritis Rheum. 1990 Apr;33(4):457–465. doi: 10.1002/art.1780330401. [DOI] [PubMed] [Google Scholar]
  221. Schwartz B., Elliott J. A., Butler J. C., Simon P. A., Jameson B. L., Welch G. E., Facklam R. R. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis. 1992 Aug;15(2):277–284. doi: 10.1093/clinids/15.2.277. [DOI] [PubMed] [Google Scholar]
  222. See R. H., Krystal G., Chow A. W. Binding competition of toxic shock syndrome toxin 1 and other staphylococcal exoproteins for receptors on human peripheral blood mononuclear cells. Infect Immun. 1990 Jul;58(7):2392–2396. doi: 10.1128/iai.58.7.2392-2396.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Seth A., Stern L. J., Ottenhoff T. H., Engel I., Owen M. J., Lamb J. R., Klausner R. D., Wiley D. C. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature. 1994 May 26;369(6478):324–327. doi: 10.1038/369324a0. [DOI] [PubMed] [Google Scholar]
  224. Shu S., Krinock R. A., Matsumura T., Sussman J. J., Fox B. A., Chang A. E., Terman D. S. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. J Immunol. 1994 Feb 1;152(3):1277–1288. [PubMed] [Google Scholar]
  225. Sissons J. G. Superantigens and infectious disease. Lancet. 1993 Jun 26;341(8861):1627–1629. doi: 10.1016/0140-6736(93)90765-9. [DOI] [PubMed] [Google Scholar]
  226. Skansén-Saphir U., Andersson J., Björk L., Andersson U. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur J Immunol. 1994 Apr;24(4):916–922. doi: 10.1002/eji.1830240420. [DOI] [PubMed] [Google Scholar]
  227. Smith H. P., Le P., Woodland D. L., Blackman M. A. T cell receptor alpha-chain influences reactivity to Mls-1 in V beta 8.1 transgenic mice. J Immunol. 1992 Aug 1;149(3):887–896. [PubMed] [Google Scholar]
  228. Soos J. M., Russell J. K., Jarpe M. A., Pontzer C. H., Johnson H. M. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules. Biochem Biophys Res Commun. 1993 Mar 31;191(3):1211–1217. doi: 10.1006/bbrc.1993.1346. [DOI] [PubMed] [Google Scholar]
  229. Soos J. M., Schiffenbauer J., Johnson H. M. Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol. 1993 Mar;43(1-2):39–43. doi: 10.1016/0165-5728(93)90073-8. [DOI] [PubMed] [Google Scholar]
  230. Sottini A., Imberti L., Gorla R., Cattaneo R., Primi D. Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis. Eur J Immunol. 1991 Feb;21(2):461–466. doi: 10.1002/eji.1830210231. [DOI] [PubMed] [Google Scholar]
  231. Spero L., Morlock B. A. Biological activities of the peptides of staphylococcal enterotoxin C formed by limited tryptic hydrolysis. J Biol Chem. 1978 Dec 25;253(24):8787–8791. [PubMed] [Google Scholar]
  232. Spertini F., Spits H., Geha R. S. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7533–7537. doi: 10.1073/pnas.88.17.7533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Steinman L., Oksenberg J. R., Bernard C. C. Association of susceptibility to multiple sclerosis with TCR genes. Immunol Today. 1992 Feb;13(2):49–51. doi: 10.1016/0167-5699(92)90133-R. [DOI] [PubMed] [Google Scholar]
  234. Stevens D. L. Invasive group A streptococcus infections. Clin Infect Dis. 1992 Jan;14(1):2–11. doi: 10.1093/clinids/14.1.2. [DOI] [PubMed] [Google Scholar]
  235. Stevens D. L., Tanner M. H., Winship J., Swarts R., Ries K. M., Schlievert P. M., Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989 Jul 6;321(1):1–7. doi: 10.1056/NEJM198907063210101. [DOI] [PubMed] [Google Scholar]
  236. Stockinger B., Pessara U., Lin R. H., Habicht J., Grez M., Koch N. A role of Ia-associated invariant chains in antigen processing and presentation. Cell. 1989 Feb 24;56(4):683–689. doi: 10.1016/0092-8674(89)90590-4. [DOI] [PubMed] [Google Scholar]
  237. Stollerman G. H. Rheumatogenic group A streptococci and the return of rheumatic fever. Adv Intern Med. 1990;35:1–25. [PubMed] [Google Scholar]
  238. Stollerman G. H. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 1):131–142. doi: 10.1016/s0090-1229(05)80019-4. [DOI] [PubMed] [Google Scholar]
  239. Sumida T., Yonaha F., Maeda T., Tanabe E., Koike T., Tomioka H., Yoshida S. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest. 1992 Feb;89(2):681–685. doi: 10.1172/JCI115635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Surman S., Deckhut A. M., Blackman M. A., Woodland D. L. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. J Immunol. 1994 May 15;152(10):4893–4902. [PubMed] [Google Scholar]
  241. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801–806. doi: 10.1038/359801a0. [DOI] [PubMed] [Google Scholar]
  242. Takei S., Arora Y. K., Walker S. M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J Clin Invest. 1993 Feb;91(2):602–607. doi: 10.1172/JCI116240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Talkington D. F., Schwartz B., Black C. M., Todd J. K., Elliott J., Breiman R. F., Facklam R. R. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun. 1993 Aug;61(8):3369–3374. doi: 10.1128/iai.61.8.3369-3374.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Thibodeau J., Labrecque N., Denis F., Huber B. T., Sékaly R. P. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules. J Exp Med. 1994 Mar 1;179(3):1029–1034. doi: 10.1084/jem.179.3.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Ting J. P., Baldwin A. S. Regulation of MHC gene expression. Curr Opin Immunol. 1993 Feb;5(1):8–16. doi: 10.1016/0952-7915(93)90074-3. [DOI] [PubMed] [Google Scholar]
  246. Todd J. K. Toxic shock syndrome. Clin Microbiol Rev. 1988 Oct;1(4):432–446. doi: 10.1128/cmr.1.4.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
  248. Tomai M. A., Aelion J. A., Dockter M. E., Majumdar G., Spinella D. G., Kotb M. T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J Exp Med. 1991 Jul 1;174(1):285–288. doi: 10.1084/jem.174.1.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Tomai M. A., Schlievert P. M., Kotb M. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun. 1992 Feb;60(2):701–705. doi: 10.1128/iai.60.2.701-705.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Tomai M., Kotb M., Majumdar G., Beachey E. H. Superantigenicity of streptococcal M protein. J Exp Med. 1990 Jul 1;172(1):359–362. doi: 10.1084/jem.172.1.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Torres B. A., Griggs N. D., Johnson H. M. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens. Nature. 1993 Jul 8;364(6433):152–154. doi: 10.1038/364152a0. [DOI] [PubMed] [Google Scholar]
  252. Toyonaga B., Mak T. W. Genes of the T-cell antigen receptor in normal and malignant T cells. Annu Rev Immunol. 1987;5:585–620. doi: 10.1146/annurev.iy.05.040187.003101. [DOI] [PubMed] [Google Scholar]
  253. Toyonaga B., Yoshikai Y., Vadasz V., Chin B., Mak T. W. Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8624–8628. doi: 10.1073/pnas.82.24.8624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  255. Tsujimoto M., Yokota S., Vilcek J., Weissmann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun. 1986 Jun 30;137(3):1094–1100. doi: 10.1016/0006-291x(86)90337-2. [DOI] [PubMed] [Google Scholar]
  256. Uchiyama T., Miyoshi-Akiyama T., Kato H., Fujimaki W., Imanishi K., Yan X. J. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol. 1993 Oct 15;151(8):4407–4413. [PubMed] [Google Scholar]
  257. Unanue E. R., Cerottini J. C. Antigen presentation. FASEB J. 1989 Nov;3(13):2496–2502. doi: 10.1096/fasebj.3.13.2572499. [DOI] [PubMed] [Google Scholar]
  258. Vandenbark A. A., Chou Y. K., Bourdette D. N., Whitham R., Hashim G. A., Offner H. T cell receptor peptide therapy for autoimmune disease. J Autoimmun. 1992 Apr;5 (Suppl A):83–92. doi: 10.1016/0896-8411(92)90023-j. [DOI] [PubMed] [Google Scholar]
  259. Waage A., Brandtzaeg P., Espevik T., Halstensen A. Current understanding of the pathogenesis of gram-negative shock. Infect Dis Clin North Am. 1991 Dec;5(4):781–791. [PubMed] [Google Scholar]
  260. Waanders G. A., Shakhov A. N., Held W., Karapetian O., Acha-Orbea H., MacDonald H. R. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med. 1993 May 1;177(5):1359–1366. doi: 10.1084/jem.177.5.1359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Wahl C., Miethke T., Heeg K., Wagner H. Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen. Eur J Immunol. 1993 May;23(5):1197–1200. doi: 10.1002/eji.1830230536. [DOI] [PubMed] [Google Scholar]
  262. Wallgren A., Festin R., Gidlöf C., Dohlsten M., Kalland T., Tötterman T. H. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells. Blood. 1993 Aug 15;82(4):1230–1238. [PubMed] [Google Scholar]
  263. Wang B., Schlievert P. M., Gaber A. O., Kotb M. Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J Immunol. 1993 Aug 1;151(3):1419–1429. [PubMed] [Google Scholar]
  264. Watanabe-Ohnishi R., Aelion J., LeGros L., Tomai M. A., Sokurenko E. V., Newton D., Takahara J., Irino S., Rashed S., Kotb M. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol. 1994 Feb 15;152(4):2066–2073. [PubMed] [Google Scholar]
  265. Webb S. R., O'Rourke A. M., Sprent J. Factors influencing the fate of T cells responding to Mls antigens. Semin Immunol. 1992 Oct;4(5):329–336. [PubMed] [Google Scholar]
  266. Weber G. F., Cantor H. HIV glycoprotein as a superantigen. A mechanism of autoimmunity and implications for a vaccination strategy. Med Hypotheses. 1993 Sep;41(3):247–250. doi: 10.1016/0306-9877(93)90241-h. [DOI] [PubMed] [Google Scholar]
  267. White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989 Jan 13;56(1):27–35. doi: 10.1016/0092-8674(89)90980-x. [DOI] [PubMed] [Google Scholar]
  268. White J., Pullen A., Choi K., Marrack P., Kappler J. W. Antigen recognition properties of mutant V beta 3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J Exp Med. 1993 Jan 1;177(1):119–125. doi: 10.1084/jem.177.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Wilson R. K., Lai E., Concannon P., Barth R. K., Hood L. E. Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev. 1988 Jan;101:149–172. doi: 10.1111/j.1600-065x.1988.tb00736.x. [DOI] [PubMed] [Google Scholar]
  270. Woodland D. L., Blackman M. A. How do T-cell receptors, MHC molecules and superantigens get together? Immunol Today. 1993 May;14(5):208–212. doi: 10.1016/0167-5699(93)90164-G. [DOI] [PubMed] [Google Scholar]
  271. Woodland D. L., Blackman M. A. Retroviral super-antigens and T cells. Int Rev Immunol. 1992;8(4):311–325. doi: 10.3109/08830189209053515. [DOI] [PubMed] [Google Scholar]
  272. Wucherpfennig K. W., Newcombe J., Li H., Keddy C., Cuzner M. L., Hafler D. A. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med. 1992 Apr 1;175(4):993–1002. doi: 10.1084/jem.175.4.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Wucherpfennig K. W., Ota K., Endo N., Seidman J. G., Rosenzweig A., Weiner H. L., Hafler D. A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 1990 May 25;248(4958):1016–1019. doi: 10.1126/science.1693015. [DOI] [PubMed] [Google Scholar]
  274. Yu C. E., Ferretti J. J. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun. 1989 Dec;57(12):3715–3719. doi: 10.1128/iai.57.12.3715-3719.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Yutsudo T., Murai H., Gonzalez J., Takao T., Shimonishi Y., Takeda Y., Igarashi H., Hinuma Y. A new type of mitogenic factor produced by Streptococcus pyogenes. FEBS Lett. 1992 Aug 10;308(1):30–34. doi: 10.1016/0014-5793(92)81043-l. [DOI] [PubMed] [Google Scholar]
  276. Zaller D. M., Osman G., Kanagawa O., Hood L. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies. J Exp Med. 1990 Jun 1;171(6):1943–1955. doi: 10.1084/jem.171.6.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Zhang J., Medaer R., Stinissen P., Hafler D., Raus J. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science. 1993 Sep 10;261(5127):1451–1454. doi: 10.1126/science.7690157. [DOI] [PubMed] [Google Scholar]
  278. Zumla A. Superantigens, T cells, and microbes. Clin Infect Dis. 1992 Aug;15(2):313–320. doi: 10.1093/clinids/15.2.313. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES